Detalles de la búsqueda
1.
An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer.
Oncologist
; 27(12): 1058-1066, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36124638
2.
Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: Real-world evidence.
J Am Acad Dermatol
; 86(4): 758-765, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34756933
3.
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab.
Int J Gynecol Cancer
; 2022 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973737
4.
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study.
Ann Rheum Dis
; 80(1): 96-102, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32719038
5.
Patient-reported barriers to statin adherence: Excerpts from a motivational interviewing intervention in older adults.
J Am Pharm Assoc (2003)
; 61(1): 60-67.e1, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33032947
6.
Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions.
Cardiovasc Drugs Ther
; 32(3): 273-280, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29855748
7.
Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol.
Cardiovasc Drugs Ther
; 32(4): 397-404, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30062465
8.
Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study.
Am Heart J
; 194: 25-38, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29223433
9.
Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng et al.
Ann Rheum Dis
; 81(11): e225, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177102
10.
The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients.
BMC Cancer
; 16: 564, 2016 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27473121
11.
Fatigue heralding multiple sclerosis.
Mult Scler
; 19(11): 1526-32, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23439577
12.
High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab.
Arthritis Res Ther
; 22(1): 250, 2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33081825
13.
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians.
Rheumatol Ther
; 7(2): 383-400, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32318979
14.
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan.
Rheumatol Ther
; 7(3): 517-535, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32440826
15.
Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes.
Arthritis Res Ther
; 22(1): 70, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32264972
16.
Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis.
Am Health Drug Benefits
; 12(8): 400-409, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32030116
17.
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension.
RMD Open
; 5(2): e001017, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31673415
18.
Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence.
J Manag Care Spec Pharm
; 25(10): 1053-1062, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31556824
19.
Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults.
Am Health Drug Benefits
; 12(4): 202-211, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31428238
20.
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies.
Clinicoecon Outcomes Res
; 10: 805-819, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30532571